CTI BioPharma
CTIC
#5665
Rank
A$1.78 B
Marketcap
A$13.56
Share price
0.00%
Change (1 day)
21.87%
Change (1 year)

Market capitalization of CTI BioPharma (CTIC)

Last known market cap: A$1.78 Billion

On August 25, 2023 CTI BioPharma had a market cap of A$1.78 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of CTI BioPharma from 2001 to 2023

End of year Market Cap

Year Marketcap Change
2023A$1.75 B57.01%
2022A$1.12 B238.82%
2021A$0.33 B4.07%
2020A$0.31 B142.91%
2019A$0.13 B116.69%
2018A$60.38 M-59.06%
2017A$0.14 B-7.6%
2016A$0.15 B-66.29%
2015A$0.47 B-7.1%
2014A$0.50 B63.59%
2013A$0.31 B126.79%
2012A$0.13 B-37%
2011A$0.21 B-25.42%
2010A$0.29 B-60.97%
2009A$0.74 B6356.92%
2008A$11.6 M-89.5%
2007A$0.11 B-65.58%
2006A$0.32 B50.02%
2005A$0.21 B-66.66%
2004A$0.64 B61.9%
2003A$0.39 B-5.99%
2002A$0.42 B-73.57%
2001A$1.59 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
A$266.34 B 14,790.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$164.87 B 9,117.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
A$29.55 B 1,552.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A$14.51 B 711.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.433 T 80,037.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$53.99 B 2,918.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
A$398.33 B 22,169.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland